{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:59:24Z","timestamp":1794560364359,"version":"4.9.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Vaccination aims to prevent or mitigate disease by priming the immune system prior to infection. While historical vaccine development relied mostly on trial-and-error, modern approaches have become more directed. By leveraging our growing understanding of pathogen biology and immune correlates of protection, we can design vaccines in ways that promote protective responses. However, the complexity of many pathogens (e.g., bacteria and fungi), as well as our immune responses against them, continue to present important challenges for vaccine development.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>Here, we demonstrate the utility of the PepSeq platform for highly multiplexed serology to both broadly and finely characterize antibody responses against complex pathogens, using the bacterium, <jats:italic>Burkholderia pseudomallei<\/jats:italic>, as a case study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We designed and synthesized three diverse pools of DNA-barcoded peptides (i.e., PepSeq libraries) and used them to characterize antibodies against a variety of <jats:italic>B. pseudomallei<\/jats:italic> proteins.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Epitope-resolved antibody binding profiles were generated for 85 individuals with culture-confirmed melioidosis, 89 US blood bank controls, and 6 monoclonal antibodies. Using these data, we identify novel B cell antigens\/epitopes and finely characterize the epitopes of three monoclonal antibodies against the <jats:italic>B. pseudomallei<\/jats:italic> GroEL protein.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Highly multiplexed serology platforms, like PepSeq, enable more comprehensive characterization of antibodies, both polyclonal and monoclonal, which can aid in the development of vaccines, diagnostics and therapeutics, even for pathogens with large, complex genomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1605758","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:27:58Z","timestamp":1751520478000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["PepSeq as a highly multiplexed platform for melioidosis antigen discovery and vaccine development"],"prefix":"10.3389","volume":"16","author":[{"given":"Evan A.","family":"Elko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H. D.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcellene A.","family":"Gates-Hollingsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia A.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata G.","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Allender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Woerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"AuCoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Altin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Keim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik W.","family":"Settles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason T.","family":"Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.128","article-title":"Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline","volume":"29","author":"Davis","year":"2011","journal-title":"Vaccine"},{"key":"B2","first-page":"1","volume-title":"Vaccines","author":"Plotkin","year":"2008"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab483","article-title":"Harnessing the potential of multiomics studies for precision medicine in infectious disease","volume":"8","author":"Ward","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0967772016670558","article-title":"Karl otto landsteiner (1868\u20131943). Physician\u2013biochemist\u2013immunologist","volume":"27","author":"Goldman","year":"2019","journal-title":"J Med Biogr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2022.08.002","article-title":"From magic bullets to modern therapeutics: Paul Ehrlich, the German immunobiologist and physician coined the term \u2018complement.\u2019","volume":"150","author":"Zipfel","year":"2022","journal-title":"Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037441","article-title":"A highly scalable peptide-based assay system for proteomics","volume":"7","author":"Kozlov","year":"2012","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41596-022-00766-8","article-title":"PepSeq: a fully in vitro platform for highly multiplexed serology using customizable DNA-barcoded peptide libraries","volume":"18","author":"Henson","year":"2023","journal-title":"Nat Protoc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/s41467-023-37378-z","article-title":"Virome-wide detection of natural infection events and the associated antibody dynamics using longitudinal highly-multiplexed serology","volume":"14","author":"Kelley","year":"2023","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100189","article-title":"Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses","volume":"2","author":"Ladner","year":"2021","journal-title":"Cell Rep Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02873-22","article-title":"Highly multiplexed serology for nonhuman mammals","volume":"10","author":"Schuettenberg","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111022","article-title":"COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins","volume":"40","author":"Elko","year":"2022","journal-title":"Cell Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00127-24","article-title":"Mapping\u00a0disparities in viral infection rates using highly multiplexed serology","volume":"9","author":"Pi\u00f1a","year":"2024","journal-title":"mSphere"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2007.05050","article-title":"PepSIRF: a flexible and comprehensive tool for the analysis of data from highly-multiplexed DNA-barcoded peptide assays","author":"Fink","year":"2020","journal-title":"arXiv."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2207.11509","article-title":"PepSIRF + QIIME 2: software tools for automated, reproducible analysis of highly-multiplexed serology data","author":"Brown","year":"2022","journal-title":"arXiv."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00022-0","article-title":"The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation","volume":"21","author":"Currie","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011072","article-title":"Development and evaluation of a multiplex serodiagnostic bead assay (BurkPx) for accurate melioidosis diagnosis","volume":"17","author":"Settles","year":"2023","journal-title":"PloS Negl Trop Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006851","article-title":"Caprine humoral response to Burkholderia pseudomallei antigens during acute melioidosis from aerosol exposure","volume":"13","author":"Yi","year":"2019","journal-title":"PloS Negl Trop Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1294113","article-title":"Deciphering the human antibody response against Burkholderia pseudomallei during melioidosis using a comprehensive immunoproteome approach","volume":"14","author":"Wagner","year":"2023","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253084","article-title":"GroEL is an immunodominant surface-exposed antigen of Rickettsia typhi","volume":"16","author":"Rauch","year":"2021","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.2.2.149-155.1995","article-title":"Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause false-positive titers of antibody to H. pylori","volume":"2","author":"Johansen","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099847","article-title":"B-cell epitopes in groEL of francisella tularensis","volume":"9","author":"Lu","year":"2014","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.femsim.2004.10.009","article-title":"Antibody response to GroEL varies in patients with acuteMycoplasma pneumoniaeinfection","volume":"43","author":"Ben\u010dina","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040773","article-title":"Understanding groEL and dnaK stress response proteins as antigens for bacterial diseases","volume":"8","author":"Fourie","year":"2020","journal-title":"Vaccines"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010287","article-title":"Development of a dual antigen lateral flow immunoassay for detecting Yersinia pestis","volume":"16","author":"Hau","year":"2022","journal-title":"PloS Negl Trop Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.332","article-title":"The large-scale blast score ratio (LS-BSR) pipeline: a method to rapidly compare genetic content between bacterial genomes","volume":"2","author":"Sahl","year":"2014","journal-title":"PeerJ"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinf"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0879-y","article-title":"Commonality despite exceptional diversity in the baseline human antibody repertoire","volume":"566","author":"Briney","year":"2019","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00846-16","article-title":"The effects of signal erosion and core genome reduction on the identification of diagnostic markers","volume":"7","author":"Sahl","year":"2016","journal-title":"mBio"},{"key":"B29","unstructured":"Luminex platform\n          \n          \n          2025"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.044","article-title":"High-throughput identification of proteins with AMPylation\u00a0using self-assembled human protein (NAPPA) microarrays","volume":"10","author":"Yu","year":"2015","journal-title":"Nat Protoc"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02239-13","article-title":"Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare","volume":"52","author":"Sarovich","year":"2014","journal-title":"J Clin Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1605758\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:28:04Z","timestamp":1751520484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1605758\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2025.1605758"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605758","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605758.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605758.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605758.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605758.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605758.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605758.s006","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"article-number":"1605758"}}